Arunjyothi Bio Ventures Limited (BOM:530881)
India · Delayed Price · Currency is INR 4.730
-0.010 (-0.21%)
At close: Sep 3, 2026
Arunjyothi Bio Ventures Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 887 | 1,198 | 2,496 | 118 | 375 | 52 | |
Market Cap Growth | -33.43% | -51.98% | 2014.21% | -68.55% | 625.00% | 264.43% |
Enterprise Value | 1,109 | 1,439 | 3,009 | 533 | 375 | 51 |
Last Close Price | 4.76 | 6.43 | 13.39 | 5.70 | 3.32 | 0.46 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | - | 321.36 | 92.03 |
PS Ratio | 3.26 | 4.32 | 8.95 | 0.58 | 21.63 | 1.74 |
PB Ratio | 3.09 | 4.17 | 7.51 | 6.68 | 17.74 | 2.59 |
P/TBV Ratio | 3.09 | 4.18 | 7.51 | 6.68 | 17.74 | 2.59 |
P/FCF Ratio | 11.90 | 16.08 | - | - | - | - |
P/OCF Ratio | 8.56 | 11.56 | 154.20 | 1.87 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 4.07 | 5.19 | 10.79 | 2.61 | 21.63 | 1.72 |
EV/EBITDA Ratio | 76.75 | 49.61 | 61.28 | 19.15 | - | - |
EV/EBIT Ratio | - | - | 153.01 | 69.22 | 227.03 | 66.19 |
EV/FCF Ratio | 14.87 | 19.31 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.78 | 0.78 | 0.79 | 29.10 | 15.26 | - |
Debt / EBITDA Ratio | 15.42 | 7.46 | 5.25 | 18.47 | - | - |
Debt / FCF Ratio | - | 2.99 | - | - | - | - |
Net Debt / Equity Ratio | 0.77 | 0.77 | 0.77 | 29.05 | 15.24 | 0.00 |
Net Debt / EBITDA Ratio | 15.33 | 7.64 | 5.22 | 18.44 | - | - |
Net Debt / FCF Ratio | - | 2.97 | -5.79 | -3.15 | -1.00 | 0.01 |
Asset Turnover | - | 0.48 | 0.48 | 0.46 | 0.09 | 0.87 |
Inventory Turnover | - | 0.52 | 2.11 | 6.22 | - | - |
Quick Ratio | - | 0.34 | 0.43 | 0.60 | 0.53 | 5.83 |
Current Ratio | - | 0.43 | 1.36 | 2.24 | 3.64 | 11.67 |
Return on Equity (ROE) | - | -14.64% | -1.58% | -17.97% | 5.67% | 2.85% |
Return on Assets (ROA) | - | -0.38% | 2.13% | 1.07% | 0.54% | 1.42% |
Return on Invested Capital (ROIC) | -3.96% | -0.65% | 3.51% | 1.76% | 0.67% | 3.65% |
Return on Capital Employed (ROCE) | - | -0.90% | 4.00% | 1.60% | 0.50% | 3.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -6.73% | -3.79% | -0.11% | -2.96% | 0.31% | 1.09% |
FCF Yield | 8.40% | 6.22% | -1.77% | -138.15% | -85.93% | -15.10% |
Buyback Yield / Dilution | -2.33% | -4.94% | -757.63% | 0.01% | -0.01% | - |